Akebia Therapeutics
AKBA
$1.32
Share price
-1.49%
Change (1 day)
45.05%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.24 B
According to Akebia Therapeutics's latest financial reports the company's total assets are $0.24 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Akebia Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.24 B | -32.12% |
| 2022-12-31 | $0.35 B | -32.74% |
| 2021-12-31 | $0.52 B | -17.82% |
| 2020-12-31 | $0.64 B | -16.48% |
| 2019-12-31 | $0.77 B | -22.61% |
| 2018-12-31 | $0.99 B | 173.59% |
| 2017-12-31 | $0.36 B | 21.33% |
| 2016-12-31 | $0.30 B | 110.03% |
| 2015-12-31 | $0.14 B | 28.78% |
| 2014-12-31 | $0.11 B | 220.19% |
| 2013-12-31 | $34.66 M | 1444.87% |
| 2012-12-31 | $2.24 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 69,223.92% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 38,928.89% | 🇨🇭 Switzerland |
 Amgen AMGN | $97.15 B | 40,095.61% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.39 B | 64.68% | 🇺🇸 USA |